美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Adamas Pharmaceuticals, Inc.

8.22

0.0000

成交量：- -

成交額：- -

市值：3.76億

市盈率：-5.08

高：8.22

開：8.22

低：8.22

收：8.22

52周最高：8.22

52周最低：8.22

股本：4,578.70萬

流通股本：2,963.92萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-1.6184

每股收益(LYR):-2.0280

淨資產收益率：1075.59%

總資產收益率：-15.40%

市淨率：-17.42

市盈率(LYR):-4.05

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Adamas Pharmaceuticals, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.adamaspharma.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Adamas Pharmaceuticals, Inc.於2000年11月15日在特拉華州註冊，是一家專業製藥公司，致力於治療中樞神經系統引起的慢性疾病，或改善中樞神經系統對人們生活的影響。該公司通過創建單一使用的新穎療法和固定劑量複合劑，來實現這一目標。公司正在開發自主研發的候選產品ADS- 5102，可用於治療帕金森病的併發症，和用於治療外創性腦損傷引起的慢性行為癥狀。Adamas已經成功地完成了該階段三分之二的臨床試驗，試驗中患者接受ADS- 5102后，帕金森病顯著減少了43%，並打算開展第三階段，於2014年申請註冊試驗。Adamas的晚期治療組合還包括一項正在進行新藥申請的與Forest實驗室聯合開發的MDX- 8704，用於治療由阿爾茨海默氏症引起的中度到重度痴獃，以及得到FDA批准正在市場上銷售的Namenda XR。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/ADMS/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ADMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADMS\",,,,,undefined,":{"symbol":"ADMS","market":"US","secType":"STK","nameCN":"Adamas Pharmaceuticals, Inc.","latestPrice":8.22,"timestamp":1789502400000,"preClose":8.22,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":29639230,"shares":45786965,"eps":-1.618448,"marketStatus":"停牌","change":0,"latestTime":"09-15 16:00:00 EDT","open":8.22,"high":8.22,"low":8.22,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.618448,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1397102400000,"exchange":"NASDAQ","adjPreClose":8.22,"volumeRatio":0,"impliedVol":1.485,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADMS\",,,,,undefined,":{"symbol":"ADMS","floatShares":29639230,"roa":"-15.40%","roe":"1075.59%","lyrEps":-2.028016,"shares":45786965,"dividePrice":0,"high":8.22,"amplitude":0,"preClose":8.22,"low":8.22,"week52Low":8.22,"pbRate":"-17.42","week52High":8.22,"institutionHeld":0,"latestPrice":8.22,"eps":-1.618448,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.618448,"open":8.22,"prevYearClose":8.22,"prevWeekClose":8.22,"prevMonthClose":8.22,"prevQuarterClose":8.22,"fiveDayClose":8.22,"twentyDayClose":8.22,"sixtyDayClose":8.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-11-26","symbol":"ADMS","reason":null,"defaultRemindTime":1637937000000,"announcedDate":"2021-11-17","type":"delisting","dateTimestamp":1637902800000},{"market":"US","date":"2021-08-09","symbol":"ADMS","fiscalQuarterEnding":"2021/06","expectedEps":-0.27,"name":null,"time":"盤後","type":"earning","dateTimestamp":1628481600000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2021-05-10","symbol":"ADMS","fiscalQuarterEnding":"2021/03","expectedEps":-0.48,"name":null,"time":"盤後","type":"earning","dateTimestamp":1620619200000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2021-02-23","symbol":"ADMS","fiscalQuarterEnding":"2020/12","expectedEps":-0.53,"name":null,"time":"盤後","type":"earning","dateTimestamp":1614056400000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2020-11-05","symbol":"ADMS","fiscalQuarterEnding":"2020/09","expectedEps":-0.5,"name":null,"time":"盤後","type":"earning","dateTimestamp":1604552400000,"reportTimeType":"post","actualEps":-0.42}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADMS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADMS","date":"2021-11-24","current":-5.07894,"percent":0.403707,"low":-17.414484,"twenty":-11.191528,"median":-4.000606,"eighty":-1.373314,"high":-0.529971,"avg":-5.665111,"sd":4.528488,"marketCap":376368852},"quantilePoints":[{"date":"2021-09-17","current":-3.930247,"twenty":-11.50223,"median":-4.073858,"eighty":-1.373776,"marketCap":216580164},{"date":"2021-09-24","current":-4.021263,"twenty":-11.461601,"median":-4.044018,"eighty":-1.373776,"marketCap":221595704},{"date":"2021-10-01","current":-4.062634,"twenty":-11.412147,"median":-4.037811,"eighty":-1.373776,"marketCap":223875495},{"date":"2021-10-08","current":-3.731666,"twenty":-11.392437,"median":-4.000606,"eighty":-1.373776,"marketCap":205637166},{"date":"2021-10-15","current":-6.677282,"twenty":-11.329935,"median":-4.000606,"eighty":-1.373314,"marketCap":367958299},{"date":"2021-10-22","current":-6.633114,"twenty":-11.317309,"median":-4.000606,"eighty":-1.373314,"marketCap":365524376},{"date":"2021-10-29","current":-6.743871,"twenty":-11.277346,"median":-4.000606,"eighty":-1.373314,"marketCap":371627755},{"date":"2021-11-05","current":-6.793703,"twenty":-11.254253,"median":-4.000606,"eighty":-1.373314,"marketCap":374373773},{"date":"2021-11-12","current":-5.987324,"twenty":-11.254253,"median":-4.000606,"eighty":-1.373314,"marketCap":375453113},{"date":"2021-11-19","current":-5.958118,"twenty":-11.194482,"median":-4.000606,"eighty":-1.373314,"marketCap":373621634},{"date":"2021-11-24","current":-6.001927,"twenty":-11.191528,"median":-4.000606,"eighty":-1.373314,"marketCap":376368852}],"updateTime":1789525418653},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.adamaspharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":-0.0244},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.1479},{"period":"1year","weight":0.146},{"period":"ytd","weight":0.1107}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Adamas Pharmaceuticals, Inc.於2000年11月15日在特拉華州註冊，是一家專業製藥公司，致力於治療中樞神經系統引起的慢性疾病，或改善中樞神經系統對人們生活的影響。該公司通過創建單一使用的新穎療法和固定劑量複合劑，來實現這一目標。公司正在開發自主研發的候選產品ADS- 5102，可用於治療帕金森病的併發症，和用於治療外創性腦損傷引起的慢性行為癥狀。Adamas已經成功地完成了該階段三分之二的臨床試驗，試驗中患者接受ADS- 5102后，帕金森病顯著減少了43%，並打算開展第三階段，於2014年申請註冊試驗。Adamas的晚期治療組合還包括一項正在進行新藥申請的與Forest實驗室聯合開發的MDX- 8704，用於治療由阿爾茨海默氏症引起的中度到重度痴獃，以及得到FDA批准正在市場上銷售的Namenda XR。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.040471},{"month":2,"riseRate":0.3,"avgChangeRate":-0.048039},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.059547},{"month":4,"riseRate":0.363636,"avgChangeRate":0.048681},{"month":5,"riseRate":0.083333,"avgChangeRate":-0.04401},{"month":6,"riseRate":0.333333,"avgChangeRate":0.051853},{"month":7,"riseRate":0.083333,"avgChangeRate":-0.032635},{"month":8,"riseRate":0.333333,"avgChangeRate":0.095898},{"month":9,"riseRate":0.25,"avgChangeRate":-0.036895},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.02531},{"month":11,"riseRate":0.545455,"avgChangeRate":0.110439},{"month":12,"riseRate":0.3,"avgChangeRate":0.042149}],"exchange":"NASDAQ","name":"Adamas Pharmaceuticals, Inc.","nameEN":"Adamas Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ADMS\",market:\"US\",,,undefined,":null}}